STLR Link Roundup – April 16, 2014

Patent Reform Bill Delayed Again The Senate Judiciary Committee has delayed consideration of the patent reform bill yet again. The bi-partisan bill, aimed at combatting patent trolls or non-practicing entities, was widely expected to go before the committee this week. However, by Monday evening, hopes had begun to fade as negotiations continued into the night. Senator Patrick Leahy, Chairman of the Judiciary Committee, issued a statement promising a new version of the bill would be Continue Reading →

STLR Link Roundup – October 19, 2013

Quest Diagnostics releases BRCA gene test and preemptively sues Myriad Quest Diagnostics, Inc., one of the largest clinical laboratory companies worldwide, has released BRCAvantage, a diagnostic test for the cancer genes, BRCA1 and BRCA2.  The company initially announced its plans to introduce the tool this past June, immediately following the Supreme Court’s decision that isolated human genes are not patentable subject matter in Association for Molecular Pathology v. Myriad Genetics, Inc.   The Court, however, upheld Continue Reading →

What’s At Stake in Monsanto’s Latest Legal Headache

Last month, the Public Patent Foundation (PPF) asked the Supreme Court to hear its case challenging the validity of Monsanto’s seed patents.  If this narrative sounds familiar, that’s because it is; the case again pits the PPF and farmers against the biotech giant much like the Supreme Court case last term, Bowman v. Monsanto. While Bowman addressed critical issues of patent law raised by the self-replicating nature of transgenic seeds, the current petition in Organic Continue Reading →